Ingredient guide · Ingredient reference

CoQ10 and inflammation: a combination trial cannot isolate one ingredient

A secondary analysis found inflammatory-marker differences with selenium plus CoQ10. The combination prevents attributing the result to CoQ10 alone.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What the study found

A study of 437 older adults compared selenium plus CoQ10 with placebo during a four-year intervention. A secondary analysis examined CRP and soluble P-selectin alongside mortality follow-up. [1]

Marker trajectories favored combined supplementation. The authors characterized the analysis as hypothesis-generating, which is narrower than proof that CoQ10 treats all inflammatory conditions. [1]

What remains unanswered

Both ingredients changed together. The design cannot identify how much either ingredient contributed or whether a similar effect occurs in younger people or other nutritional settings. The authors declared no competing interests; funding was not established from the retrieved abstract. [1]

A hypothetical distinction

Imagine a recipe changes two ingredients and produces a different result. Without separate single-ingredient comparisons, the result cannot be assigned confidently to just one change.

Evidence summary — CoQ10 and inflammation
DetailInterpretation
Two active ingredientsAttribution limited
Secondary analysisHypothesis-generating
Inflammatory disease treatmentNot established
CoQ10 and inflammation: a combination trial cannot isolate one ingredient — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial - PubMed
    Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.